CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Director sold 80,000 shares at $8.14 ($651,200)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale Director sold 62,590 shares at $8.01 ($501,346)
- 4 Planned sale Director sold 17,410 shares at $8.01 ($139,454)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 17,058 shares at $8.38 ($142,946)
- 4 Open-market sale Director sold 40,000 shares at an average $8.35 ($334,074)
- 4 Open-market sale SVP, Chief Legal Officer sold 13,665 shares at $8.40 ($114,786)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, Chief Legal Officer sold 43,657 shares at $8.61 ($375,887)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 8-K/A Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
Page 9 of 35 · 695 filings